FGP
AORT icon

Freestone Grove Partners’s Artivion AORT Stock Holding History

Freestone Grove Partners’s Portfolio AORT Stock Details AORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$328K Buy
+14,607
New +$409K ﹤0.01% 737

Other funds holding AORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Freestone Grove Partners's AORT Position: Q2 2026 in Review

Freestone Grove Partners opened a new position in Artivion (AORT) in Q2 2026: 14,607 shares worth $328K. The stake represents ﹤0.01% of the portfolio and ranks #737 among its holdings.

206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Freestone Grove Partners held 14,607 shares of Artivion worth $328K as of Q2 2026.
  • Artivion was a new Freestone Grove Partners position in Q2 2026.
  • Artivion made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #737 holding.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.